Gergen Mark J
SEC insider (Form 3/4/5 filer). CIK 0001373110. Executive Chairman at Poseida Therapeutics, Inc. (PSTX). 13 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2025. Located in SAN DIEGO, CA.
Companies Gergen Mark J has filed insider reports for
- Poseida Therapeutics, Inc. (PSTX): Director, Officer, Executive Chairman
Gergen Mark J
CIK: 0001373110
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Poseida Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
172.6K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
48.1K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
75K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
342K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
518.5K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
364.1K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect636.7K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
240.7K shares- - Jan 2, 2025PSTX
Poseida Therapeutics, Inc.
Tax PaymentDirect23.3K shares at avg. $9.60$224K - Dec 10, 2024PSTX
Poseida Therapeutics, Inc.
ExerciseDirect30K shares at avg. $2.78$83K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 172,600 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 48,115 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 342,000 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 518,500 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 364,060 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Tender Offer | 636,726 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 240,721 | - | - | Direct |
| Jan 2, 2025 | PSTX Poseida Therapeutics, Inc. | Tax Payment | 23,313 | $9.60 | $223,805 | Direct |
| Dec 10, 2024 | PSTX Poseida Therapeutics, Inc. | Exercise | 30,000 | $2.78 | $83,430 | Direct |
1-10 of 13 transactions